Breast Implant Risks and Complications: The Real Numbers

From capsular contracture to BIA-ALCL, here are the sourced numbers behind breast implant risks — not just a generic warning list.

The most common complication: capsular contracture

Capsular contracture — the tightening and hardening of scar tissue that naturally forms around any implant — is the single most common complication of breast augmentation. A systematic review and meta-analysis found contracture rates in the range of roughly 11% to 19% at 10-year follow-up, and identified two variables that measurably affect that risk: implant surface and placement. Smooth implants showed meaningfully higher contracture rates than textured implants in the pooled data, while subpectoral placement (under the chest muscle) was associated with a substantially lower contracture risk than placement over the muscle. The same review noted overall secondary (revision) surgery rates ranging widely, from 0% up to 36%, across the studies analyzed at 10-year follow-up — underscoring that a meaningful share of augmentation patients eventually need at least one further procedure, for reasons that can include contracture, rupture, or a simple change in aesthetic goals over time.

Rarer but more serious: BIA-ALCL and breast implant illness

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a T-cell lymphoma the FDA has linked specifically to breast implants, appearing more frequently with textured-surface implants than smooth ones. It is rare: commonly cited lifetime risk figures for textured implants put the odds at roughly 1 in 35,000 by age 50, climbing to about 1 in 12,000 by age 70 and roughly 1 in 7,000 by age 75, with an overall lifetime estimate around 1 in 30,000 — for comparison, lifetime breast cancer risk in women is often cited around 1 in 8, so BIA-ALCL risk sits well below that, though it remains a real, FDA-recognized condition that any implant patient should be aware of, particularly with textured implants.

Separately, some patients report a cluster of symptoms — including fatigue, memory problems, rash, "brain fog," and joint pain — that they associate with their implants, a phenomenon commonly called breast implant illness (BII). The FDA is explicit that BII is "poorly understood" as a defined medical condition, distinct from BIA-ALCL, which is a specific and diagnosable lymphoma. If you experience unexplained systemic symptoms after augmentation, it's worth raising with both your surgeon and a primary care physician rather than assuming either it is or isn't implant-related without evaluation.

Other complications worth knowing about

The FDA's own list of local complications (each occurring in at least 1% of patients in its data) includes implant rupture or deflation, palpability or visibility of the implant, wrinkling and rippling, calcification, breast tissue atrophy, chest wall deformity, delayed wound healing, seroma, extrusion, tissue necrosis, breast asymmetry, ptosis (sagging), malposition, temporary or permanent changes in nipple and breast sensation, breast pain, and skin rash. Infection and hematoma, by contrast, are comparatively uncommon — a cited 10-year follow-up analysis found both occurring in less than 1% of primary augmentation patients.

When to seek prompt evaluation

Sudden breast swelling more than a year after surgery, a new persistent lump, unusual firmness or shape change, or fluid buildup around an implant should be evaluated promptly — these are also the specific symptoms associated with BIA-ALCL, which is treatable when caught early. Routine implant monitoring (including MRI or ultrasound screening at intervals your surgeon recommends) is part of standard aftercare precisely because rupture can occur without obvious symptoms, especially with silicone implants.

For typical costs and what's included, see our breast implant cost guide, and for common misconceptions about the procedure, our breast implant myths vs. facts article. Clinics in Delhi and Mumbai should be able to walk you through their own implant-monitoring protocol.